NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MysmA.10611.c: Alcohol dehydrogenase B

Target Characteristics

from organism: Mycobacterium smegmatis ATCC 700084 / mc(2)155
most recent status: soluble
center reference id: MysmA.10611.c
is community request: False
associated disease:
NIH risk group: 2
is select agent: False
NIH priority
pathogens category:
IIIC

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

External Resources

Resource Reference ID
OrthoMCL: OG5_127257
PATRIC ID: fig|246196.19.peg.5709
RefSeq: YP_890093.1
UniProt: A0R4K5

Enzyme & Pathway Information

Pathway Pathway ID EC Number
ethanol degradation I ETOH-ACETYLCOA-ANA-PWY 1.1.1.1
mixed acid fermentation FERMENTATION-PWY 1.1.1.1
heterolactic fermentation P122-PWY 1.1.1.1
acetylene degradation (anaerobic) P161-PWY 1.1.1.1
superpathway of N-acetylneuraminate degradation P441-PWY 1.1.1.1
hexitol fermentation to lactate, formate, ethanol and acetate P461-PWY 1.1.1.1
D-camphor degradation P601-PWY 1.1.1.1
ethanolamine utilization PWY0-1477 1.1.1.1
L-tryptophan degradation V (side chain pathway) PWY-3162 1.1.1.1
L-tyrosine degradation III PWY3O-4108 1.1.1.1
superpathway of fermentation (Chlamydomonas reinhardtii) PWY4LZ-257 1.1.1.1
L-valine degradation II PWY-5057 1.1.1.1
L-leucine degradation III PWY-5076 1.1.1.1
L-isoleucine degradation II PWY-5078 1.1.1.1
L-phenylalanine degradation III PWY-5079 1.1.1.1
L-methionine degradation III PWY-5082 1.1.1.1
pyruvate fermentation to ethanol I PWY-5480 1.1.1.1
pyruvate fermentation to ethanol II PWY-5486 1.1.1.1
phenylethanol biosynthesis PWY-5751 1.1.1.1
acetoin degradation PWY-6028 1.1.1.1
serotonin degradation PWY-6313 1.1.1.1
acetaldehyde biosynthesis I PWY-6333 1.1.1.1
noradrenaline and adrenaline degradation PWY-6342 1.1.1.1
pyruvate fermentation to ethanol III PWY-6587 1.1.1.1
superpathway of Clostridium acetobutylicum solventogenic fermentation PWY-6594 1.1.1.1
superpathway of Clostridium acetobutylicum acidogenic and solventogenic fermentation PWY-6604 1.1.1.1
ethanol degradation II PWY66-21 1.1.1.1
phytol degradation PWY66-389 1.1.1.1
salidroside biosynthesis PWY-6802 1.1.1.1
3-methylbutanol biosynthesis (engineered) PWY-6871 1.1.1.1
(S)-propane-1,2-diol degradation PWY-7013 1.1.1.1
pyruvate fermentation to isobutanol (engineered) PWY-7111 1.1.1.1
chitin degradation to ethanol PWY-7118 1.1.1.1
superpathway of anaerobic sucrose degradation PWY-7345 1.1.1.1
butanol and isobutanol biosynthesis (engineered) PWY-7396 1.1.1.1
dehydrodiconiferyl alcohol degradation PWY-7557 1.1.1.1

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MKTKGALIWE FNQPWSIEEI EIGDPVKDEV KIQMEASGMC HSDHHLVTGG IPMGGFPVLG GHEGAGIVTE VGPGVEGIEP GDHVVLSFIP SCGSCPSCQA GLRNLCDLGA GLLGGVAVAD GTHRIHANGK PVFPMTLLGT FSPYMVVHKS SVVKIDKSIP FEVACLVGCG VTTGYGSAVR SGDIRPGDDV AIFGIGGVGM GALQGAVNAG ARYIFAIDPV EWKRDQALKF GATHVYPDVF SAMAGIAEVT AGGMAKKVIV TVGELHGEDI DNYLNVTSKG GTCVVTAVGS MLDTNANINL AMLTLLQKNL QGTIFGGGNP HHDIPQLLSM YKAGKLNLDD MVTRQYRLEQ INDGYQDMLE GRNIRGVIRY TDADR

NT Sequence
ATGAAGACAA AAGGTGCTCT CATCTGGGAG TTCAACCAGC CGTGGTCGAT CGAGGAGATC GAGATCGGTG ACCCCGTCAA GGACGAGGTC AAGATCCAGA TGGAAGCGTC CGGGATGTGC CACTCCGATC ACCACCTGGT GACCGGCGGC ATTCCGATGG GTGGCTTCCC GGTGCTCGGC GGCCACGAGG GCGCGGGCAT CGTCACCGAG GTGGGTCCTG GCGTCGAGGG TATCGAGCCC GGCGACCACG TCGTGCTGTC GTTCATCCCG TCCTGCGGTT CGTGCCCGTC GTGTCAGGCC GGCCTGCGCA ACCTCTGCGA TCTGGGTGCG GGTCTGCTCG GTGGCGTCGC TGTCGCCGAC GGCACCCACC GCATCCACGC GAACGGCAAG CCGGTGTTCC CGATGACGCT GCTCGGCACG TTCTCGCCGT ACATGGTCGT GCACAAGAGC TCGGTGGTGA AGATCGACAA GTCGATCCCG TTCGAGGTGG CCTGCCTCGT GGGCTGCGGT GTCACCACGG GTTACGGCTC GGCCGTGCGC AGCGGTGACA TCCGCCCCGG AGACGACGTC GCGATCTTCG GCATCGGCGG TGTCGGCATG GGTGCGCTGC AGGGTGCCGT GAATGCCGGT GCGCGTTACA TCTTCGCCAT CGACCCGGTC GAGTGGAAGC GCGATCAGGC CCTGAAGTTC GGCGCCACCC ACGTCTACCC CGACGTCTTC TCGGCCATGG CCGGCATCGC CGAGGTGACC GCGGGCGGCA TGGCCAAGAA GGTCATCGTG ACCGTCGGCG AACTGCACGG TGAGGACATC GACAACTACC TCAACGTGAC CAGCAAGGGT GGCACCTGCG TGGTGACCGC GGTCGGCAGC ATGCTCGACA CCAACGCCAA CATCAACCTG GCGATGCTGA CCCTGCTGCA GAAGAACCTG CAGGGCACCA TCTTCGGTGG CGGCAACCCG CACCACGACA TCCCGCAGCT GCTGAGCATG TACAAGGCGG GCAAGCTCAA CCTCGACGAC ATGGTCACGC GCCAGTACCG CCTGGAGCAG ATCAACGACG GCTACCAGGA CATGCTCGAA GGCCGCAACA TCCGCGGCGT CATCCGCTAC ACCGACGCCG ACCGC

© 2022 Seattle Children's Research Institute. All rights reserved.